SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001640455-19-000093
Filing Date
2019-12-17
Accepted
2019-12-17 17:00:49
Documents
5
Period of Report
2019-12-17
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K jnce121720198-k.htm 8-K 32424
2 EXHIBIT 1.1 jnce12172019exhibit11.htm EX-1.1 226632
3 EXHIBIT 5.1 jnce12172019exhibit51.htm EX-5.1 15854
4 wh.jpg GRAPHIC 18919
5 whfooter2019.jpg GRAPHIC 186580
  Complete submission text file 0001640455-19-000093.txt   559227
Mailing Address 780 MEMORIAL DRIVE CAMBRIDGE MA 02139
Business Address 780 MEMORIAL DRIVE CAMBRIDGE MA 02139 857-259-3840
Jounce Therapeutics, Inc. (Filer) CIK: 0001640455 (see all company filings)

IRS No.: 454870634 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37998 | Film No.: 191290428
SIC: 2836 Biological Products, (No Diagnostic Substances)